Pictet Asset Management (Switzerland)’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $9.3M | Sell |
930,914
-133,924
| -13% | -$1.34M | 0.01% | 637 |
|
|
2023
Q1 | $9.46M | Buy |
1,064,838
+102,481
| +11% | +$910K | 0.01% | 622 |
|
|
2022
Q4 | $10.6M | Sell |
962,357
-113,992
| -11% | -$1.25M | 0.02% | 579 |
|
|
2022
Q3 | $14M | Sell |
1,076,349
-354,016
| -25% | -$4.61M | 0.02% | 502 |
|
|
2022
Q2 | $18.1M | Sell |
1,430,365
-8,917
| -0.6% | -$113K | 0.03% | 477 |
|
|
2022
Q1 | $20.2M | Buy |
1,439,282
+317,347
| +28% | +$4.45M | 0.02% | 492 |
|
|
2021
Q4 | $32.5M | Buy |
1,121,935
+194,385
| +21% | +$5.63M | 0.03% | 422 |
|
|
2021
Q3 | $27.8M | Buy |
+927,550
| New | +$27.8M | 0.03% | 440 |
|